Jocelyn Hudson

305 POSTS 0 COMMENTS

Adoption of AI into workflow associated with faster time to assessment...

An abstract presented at the 2024 American Venous Forum (AVF) annual meeting (March 3–6) revealed that, in the treatment of patients with pulmonary embolism...

US study highlights racial and ethnic disparities in the placement of...

IVC filters
A nationwide US study, recently published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL), showed that Black patients had the highest...

“Significant efforts” needed to improve level of evidence for management of...

CLOUT
A large international Delphi consensus on the management of lower extremity venous outflow obstruction has been published, identifying “clear areas of agreement and disagreement”...

Manj Gohel

“As I learned more about venous pathologies, it became abundantly clear that patients with venous disease were a largely neglected population in need of...

In the making: Data-driven venous care

The quest for more data—specifically multicenter, independently adjudicated and, where possible, randomized—in the field of venous disease continues, with various trials currently underway set...

“I still consider myself a student of leadership”: Retired Army General...

leadership
“Expect—and prepare for—the unexpected,” Karen Gibson, Sergeant at Arms at the United States Senate, told the UIP 2023 World Congress (Sept. 17–21) during a...

Approaching combined disease: Treat superficial, deep or both?

recurrent
Mona Gupta (Chicago, USA) writes about the importance of acknowledging the “complex relationship” between the deep and superficial venous systems. The complex relationship between the...

Mechanical thrombectomy demonstrates superior outcomes to anticoagulation in DVT patients, analysis...

Mechanical thrombectomy using the ClotTriever device (Inari Medical) for iliofemoral deep vein thrombosis (DVT) was found to be “associated with significantly” lower Villalta scores...

Large administrative databases enter crosshairs as comparative analysis shows percutaneous mechanical...

analysis
The pitfalls of large administrative databases came to the fore during the presentation of a propensity-match scoring analysis demonstrating that percutaneous mechanical thrombectomy (MT)...

Nitinol stents placed in iliac veins “not associated with prolonged back...

In a retrospective review of over 600 patients who underwent iliac vein stent placement, the development of back pain was found to be unrelated...

STEVECO trial provides “important evidence” in quest for individualized venous treatment

This advertorial, sponsored by Optimed, is only available in selected countries and geographies. One-year results from the STEVECO randomized controlled trial (RCT) were recently...

Venous News 17 – February 2024: US Edition

In this issue: In the making: An in-depth look at two trials that are set to provide some much-needed data for the treatment of venous...

Venous News 17 – February 2024

In this issue: In the making: An in-depth look at two trials that are set to provide some much-needed data for the treatment of...

Innova Vascular announces successful early commercial use of Laguna thrombectomy system...

Innova Vascular has announced successful early commercial use of the company's Laguna thrombectomy system. Physicians at UCLA Medical Center in Los Angeles, USA, and...

VVT Medical and Methapharm sign a distribution agreement for the marketing...

VVT Medical recently announced the signing of a strategic distribution agreement with Methapharm, a specialty pharmaceutical company. According to a press release, this collaboration marks...

Stephen Black

Stephen Black speaks to Venous News about his career to date. Despite having, in his own words, done “terribly” in an interview for a...

Venous News’ top stories of 2023

Which stories captured the attention of the venous community this year? Read our summary of the trending articles from across the Venous News network...

Multimodal imaging for venous disease: A how-to guide

Start with a duplex scan, continue with axial imaging, and then assess with venography and intravascular ultrasound (IVUS). This was the advice of Efthymios...

Intravenous anaesthesia delivery during varicose vein treatment proves safe and reduces...

anesthesia
A new intravenous anaesthesia delivery technique used during endothermal ablation for varicose veins demonstrated comparatively low pain scores according to first-in-human (FIH) data recently...

CX 2024 programme seeks to challenge venous controversy ‘head on’ to...

Forecasting their Charing Cross (CX) 2024 venous programme highlights, executive board members Manj Gohel (London, United Kingdom), Erin Murphy (Charlotte, USA) and Stephen Black...

Duo venous stent system shows 90.2% primary patency at 12 months,...

Duo
The Duo venous stent system (Vesper Medical/Philips) showed a 98.7% freedom from major adverse events (MAEs) at 30 days and 90.2% primary patency at...

Akura thrombectomy system for PE appears safe and demonstrates reduction of...

Results from a first-in-human, prospective, single-arm study of the Akura Medical thrombectomy system (Akura Medical) for pulmonary embolism (PE) were revealed this week at...

One-year CLOUT data demonstrate low rate of PTS following treatment with...

David Dexter (Sentara Vascular Specialists, Norfolk, USA) shared one-year data from the CLOUT registry this week at The VEINS 2023 (28–30 October, Las Vegas,...

Vein360 receives US FDA clearance to reprocess the Philips Visions PV...

Vein360 has announced it received US Food and Drug Administration (FDA) 510(k) clearance for reprocessing the Philips Visions PV 0.035 digital intravascular ultrasound (IVUS)...

Venous News 16 – October 2023 US Edition

In this issue: The difficulties of moving from page to practice: New guidelines and the challenges of implementation September conference round-up: Highlights from the International Union of...

Venous News 16 – October 2023

In this issue: The difficulties of moving from page to practice: New guidelines and the challenges of implementation September conference round-up: Highlights from the International...

REAL-PE demonstrates statistically significant lower major bleeding rates with Ekos system...

EkoSonic
Data from the REAL-PE study were presented this week at TCT 2023 (23–26 October, San Francisco, USA) demonstrating that patients treated for pulmonary embolism...

Thrombolex announces new insights from the RESCUE trial with the Bashir...

Thrombolex has announced never-before-reported major reductions in obstruction in all of the segmental pulmonary arteries (PA), based on independent core lab data analysis of...

Obituary: Roger M Greenhalgh 6th February 1941 – 6th October 2023

Roger Malcolm Greenhalgh, the surgeon internationally renowned for his unparalleled contribution to vascular education, training and research, died peacefully on 6th October, aged 82....

Aidoc’s AI solution for pulmonary embolism clinically proven to reduce hospital...

Research in the advancement of artificial intelligence (AI)-driven pulmonary embolism (PE) care was unveiled recently during the 9th Annual Pulmonary Embolism Symposium (Sept. 21–23)...

Erin Murphy

venous
“Occasionally, taking a step in a different direction can pave the way for substantial strides forward,” Erin Murphy, MD, tells Venous News, recalling her...

New clinical data support Viz.ai solution for improved pulmonary embolism detection...

Viz.ai has announced new clinical data supporting advancements in pulmonary embolism (PE) detection. Two studies have demonstrated the real-world clinical efficacy of Viz.ai's PE...

Deep venous valve technologies set to address “large unmet need worldwide”

deep venous
The pursuit of a cure for deep venous valvular reflux—long considered to be the “holy grail” of deep venous disease—is underway, with new technologies...

The pulmonary arterial tree—it is time we branch out

Nicolas J Mouawad (McLaren Health System, Bay City, USA) urges vascular surgeons to “get out of their comfort zone” and become more involved in...

Multi-society guidelines on varicose vein management published

varicose vein management
The Society for Vascular Surgery (SVS), American Venous Forum (AVF), and American Vein and Lymphatic Society (AVLS) have released the second and final part...

Venous News 15 – September 2023 US Edition

In this issue: Sixty years in the making: Deep venous valve technologies set to address “large unmet need worldwide” Spring/summer 2023 conference round-up: Highlights...

Venous News 15 – September 2023

In this issue: Sixty years in the making: Deep venous valve technologies set to address "large unmet need worldwide" Spring/summer 2023 conference round-up: Highlights...

Updated ClosureFast radiofrequency ablation catheter receives US FDA 510(k) clearance for...

Medtronic has announced that an updated ClosureFast radiofrequency ablation (RFA) catheter in a lower 6Fr profile is now available in the USA following 510(k)...

Pelvic venous incompetence: “Do not treat images, treat symptoms”

pelvic venous
“Everything depends on the symptoms,” Aleksandra Jaworucka-Kaczorowska, of the Center of Phlebology and Aesthetic Medicine and the Center of Surgery, Gynaecology and Obstretics in...

Child-bearing age “should not be a contraindication to venous stenting”

pregnancy
In a recently published study, dedicated venous stents performed well through pregnancy and postpartum, and a protocol including the use of low-dose antiplatelets in...

Study finds no correlation between IVC filter placement position and device...

IVC filter
Researchers report that inferior vena cava (IVC) filter placement position relative to the level of the most inferior renal vein was not associated with...

Mechanical thrombectomy: ClotTriever offers “extended window” for DVT treatment

This advertorial, sponsored by Inari Medical, is only available in selected countries and geographies. During a recent webinar hosted by Inari Medical, a multidisciplinary group...

LAMA trial: MOCA “may have a role in a small number...

LAMA
Five-year results of the LAMA randomised controlled trial (RCT) show that both mechanochemical ablation (MOCA) and modern endovenous laser ablation (EVLA) technology are associated...

Study finds similar rates of VTE in both flying and non-flying...

air travel
Uncertainty underlying the magnitude of risk posed by long distance air travel in venous thromboembolism (VTE) patients has created the need for a deeper,...

Risk of cancer-related VTE recurrence “significantly lower” using oral anticoagulants when...

cancer patient
Delivering results and recommendations from a systematic review and meta-analysis of novel oral anticoagulants (NOACs) versus low molecular weight heparin (LMWH) in the prevention...

Inari Medical announces commercial launch of RevCore and Triever16 Curve for...

Inari Medical
Inari Medical today announced the launch of two new purpose-built products, the RevCore thrombectomy catheter, and the Triever16 Curve catheter. According to a company press...

Gore announces first US enrolment for the Viafort vascular stent iliofemoral...

iliofemoral
Gore has announced that the first US patient has been enrolled in a prospective, non-randomised, multicentre, single-arm study with five-year follow-up to evaluate the...

Erasing language barriers at the UIP 2023 World Congress

Wordly
This article was provided by the American Vein & Lymphatic Society. The UIP 2023 World Congress (17–21 September, Miami Beach, USA) will bring professionals from...

Primary patency after venous stenting best in NIVL patients, study finds

A recent study concludes that non-thrombotic iliac vein lesion (NIVL) patients have better primary patency after venous stenting than patients with venous thrombotic disorders....

CX 2023: Venous, we have a perception problem

problem
Venous disease care has a problem with optics in the context of growth in the number of venous procedures and the spectre of inappropriate...

CX 2023: Multidisciplinary faculty address key issues in the pelvic venous...

pelvic
The deep venous consensus update session at the 2023 Charing Cross (CX) International Symposium (25–27 April, London, UK) covered a range of key topics...

Mechanochemical ablation with ClariVein OC: A “first choice” treatment option

ClariVein
This advertorial is sponsored by Merit Medical. The ClariVein OC endovenous occlusion catheter (Merit Medical) is associated with a good occlusion rate, comparable with other...

Akura Medical announces successful first-in-human use of its mechanical thrombectomy platform

Akura Medical
Akura Medical announced today it has initiated its first-in-human clinical study of the Akura mechanical thrombectomy platform. A press release notes that the Akura...

Cook Medical treats first patient in first-in-human clinical trial for venous...

venous valve
Cook Medical recently announced that the first patient has been treated in a clinical study to evaluate a new venous valve designed for treating...

CX 2023 seeks consensus in “rapidly” progressing venous field

The CX 2023 Venous & Lymphatic programme it set to be a “highlight” of this year’s meeting, CX co-chair and executive board member Erin...

New study demonstrates double the rate of healing of venous leg...

Geko
UK-based medical device manufacturer Sky Medical Technology today announced the International Wound Journal has published a multicentre randomised self-controlled trial (RCT) from the company. The...

First US patient enrolled in Gore Viafort vascular stent pivotal study

Viafort
W L Gore & Associates (Gore) has announced that the first US patient has been enrolled in a prospective, non-randomised, multicentre, single-arm study with...

STEVECO trial calls into question randomisation in the venous stenting field

STEVECO
Recruitment proved to be a major challenge for the STEVECO (Stent versus conservative treatment in patients with deep venous obstruction) randomised controlled trial (RCT),...

Viz.ai to expedite patient enrolment in NIH-funded PE-TRACT clinical trial

Viz.ai has announced it will use its Viz Recruit platform to optimise patient enrolment for the National Institutes of Health (NIH)-funded Pulmonary embolism—thrombus removal...

Study indicates reflux time “best utilised as a cut-off” for diagnosis...

GSV ablation
In a prospective study of patients undergoing great saphenous vein (GSV) ablation, researchers found no correlation between maximum reflux time and symptom severity as...

Educate, educate, and educate again: The continuing quest for appropriate venous...

Prominent venous disease experts discuss venous stenting, appropriate care, and the pursuit of refined data and better education in a space where part of...

Theraclion announces results of first US trial

Theraclion
Theraclion has announced the results of the first Sonovein trial in the USA, which the company describes as a "major milestone" towards receiving US...

Penumbra launches Lightning Flash mechanical thrombectomy system

Today, Penumbra announced the US Food and Drug Administration (FDA) clearance and launch of its Lightning Flash mechanical thrombectomy system. "Lightning Flash features Penumbra's novel...

Koya Medical names Thomas Maldonado as chief medical officer

Maldonado
Koya Medical recently announced the appointment of Thomas Maldonado (New York University Medical Center, New York, USA) as chief medical officer and a member of...

Multi-society guideline on venous disease, varicose veins updated

The Society for Vascular Surgery (SVS) has published an update to the SVS/American Venous Forum (AVF) 2011 clinical practice guideline on the care of...

First-in-human patients continue to benefit from VenoValve at average of three...

first-in-human
Positive long-term, three-year observational data from a cohort of patients that participated in the previously concluded VenoValve (Envveno Medical) first-in-human clinical trial were recently...

Early results and expert experience positive for the BeYond dedicated venous...

BTK
This advertorial is sponsored by Bentley. Launched in July 2020, the BeYond Venous self-expanding stent system (Bentley InnoMed GmbH) now has early clinical data and...

Thrombectomy for DVT associated with reduced ICU cost when compared with...

thrombectomy
A retrospective review, presented as a late-breaking clinical trial at The VEINS (Venous Endovascular Interventional Strategies) 2022 (30–31 October, Las Vegas, USA), indicates that...

Mechanical thrombectomy for DVT: Randomised data needed to boost growing evidence...

mechanical thrombectomy
Two datasets presented during the late-breaking clinical trials session at The VEINS (Venous Endovascular Interventional Strategies) 2022 (30–31 October, Las Vegas, USA)—the latest results...

Gore completes first-in-human implants of the Gore Viafort vascular stent

IVC
W L Gore & Associates (Gore) today announced the first implants of its investigational Gore Viafort vascular stent as part of the recently initiated...

Clinical study of Theraclion’s Sonovein solution for varicose veins completes enrolment

Theraclion
Theraclion announced at the American Vein and Lymphatic Society (AVLS) 2022 annual meeting (13–16 October, New Orleans, USA) that the final patient has been...

ABRE clinical study 36-month data show sustained effectiveness of Abre venous...

Medtronic has announced the 36-month final results from the ABRE clinical study. The purpose of the ABRE clinical study was to evaluate the safety...

FLASH results demonstrate “excellent safety profile” of the FlowTriever system in...

flash
Results of the FLASH registry demonstrate the “excellent safety profile” of the FlowTriever system (Inari Medical) in 800 “real-world” patients. This is according to...

RESCUE trial of the Bashir endovascular catheter demonstrates reduction in pulmonary...

rescue trial
Thrombolex today presented the final results of its National Institutes of Health (NIH)-sponsored RESCUE trial at TCT 2022 (16–19 September, Boston, USA). This investigational...

Experts establish international standard set of outcome measures for patients with...

varicose vein management
The International Consortium for Health Outcomes Measurement (ICHOM) venous thromboembolism (VTE) working group has developed a standard set of outcome measures for patients with...

Bentley acquires GoBack catheter from Upstream Peripheral Medical Technologies

Bentley today announced that it has acquired the rights of the GoBack catheter from Upstream Peripheral Technologies. “The acquisition of the GoBack catheter marks the...

ClotTriever deemed a “game-changer” in deep vein thrombosis treatment

This advertorial, sponsored by Inari Medical, is only available in selected countries and geographies. “I am finally very confident I have a device that...

Viz.ai receives FDA 510(k) clearance for automated RV/LV analysis algorithm

Viz.ai recently announced it has received US Food and Drug Administration (FDA) 510(k) clearance for an automated right ventricle (RV)/left ventricle (LV) ratio algorithm,...

Inspiratory and calf muscle training improve venous function and quality of...

A multicentre, prospective, randomised study published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL) showed that inspiratory muscle training (IMT), in...

Trial supports full-dose anticoagulation to prevent blood clots in COVID-19 patients

COVID-19
Treatment of critically ill COVID-19 patients with full-dose anticoagulation lowers the risk of venous and arterial clotting complications by 44% compared with the standard...

Inari Medical announces randomised controlled trial evaluating clinical outcomes of the...

ClotTriever
Inari Medical has announced planned enrolment of the DEFIANCE randomised controlled trial (RCT), which is designed to compare the clinical outcomes of patients with...

Recurrent varicose veins: Multiple tools available to achieve excellent outcomes

recurrent
Ramona Gupta (Northwestern University, Chicago, USA) addresses the issue of recurrent varicose veins, highlighting in particular the “multiple tools” now at physicians’ disposal to...

Retrospective study is “first to systematically explore predictors of venous stent...

stenting
New data indicate that venous stent failure “may be predicted by low peak flow velocity and post-thrombotic changes in inflow veins” and that endovascular...

Key differences in presentation, outcomes for distal versus proximal DVT uncovered

DVT
A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep...

Compression duration affects pain following superficial venous intervention, study finds

Roshan Bootun application of compression stockings
Postprocedural compression of one to two weeks after superficial venous incompetence (SVI) treatment is associated with reduced pain compared with a shorter duration. This...

Inari Medical announces leadership succession plan

Inari Medical
This week Inari Medical announced that chief operating officer Drew Hykes will succeed Bill Hoffman as chief executive officer, effective 1 January 2023. Hykes...

New iliac vein stent offers “safe and effective” endovascular treatment option...

Based on the findings of a multicentre, randomised controlled trial, researchers have concluded that a new iliac vein stent—the Venastent (Tianhong)—provides a “safe and...

Machine-learning software aids non-experts in performing “safe and efficient” remote DVT...

machine-learning software
In a prospective, controlled clinical trial of deep vein thrombosis (DVT) triage using artificial intelligence (AI)-guided software simulating compression ultrasonography, lead investigator Efthymios Avgerinos...

Michael Cerminaro to succeed Marvin Woodall as CEO of Thrombolex

Thrombolex bashir
Thrombolex has announced that its board of directors has named Michael Cerminaro chief executive officer (CEO) effective 13 July 2022, the date of the...

Biolitec launches ELVeS Radial 2ring Swift laser fibre

Biolitec
Biolitec recently announced the launch of a new addition to its ELVeS Radial family—the ELVeS Radial 2ring Swift fibre. According to a company press...

New data underscore benefits of Penumbra’s Indigo for submassive pulmonary embolisms...

Indigo
In a new subgroup analysis of the EXTRACT-PE trial, the Indigo aspiration system (Penumbra) was effective at improving clinical outcomes for submassive pulmonary embolism...

I-Vasc announces the first clinical use of Velex empty vein ablation...

I-Vasc, which has developed and CE marked its percutaneous Velex system to treat chronic venous insufficiency (CVI), has announced that Velex has entered clinical...

Iliac vein stenting should remain a viable treatment option for higher...

Despite greater comorbid conditions, patients with obesity benefited as much as patients with normal body mass index (BMI) from iliac vein stent placement for...

Optimed announces the presentation of two prospective venous stent trials at...

Houman Jalaie endovascular
Optimed recently announced the presentation of two prospective, multicentre trials evaluating the performance and effectiveness of their venous stent systems at the Leipzig Interventional...

No long-term advantage of endovenous laser ablation over great saphenous vein...

Ten-year follow-up of a randomised controlled trial (RCT) has shown no clear long-term advantage of endovenous laser ablation (EVLA) with a 980nm wavelength and...

VTE: Fewer recurrences with low-dose apixaban compared to discontinuation of the...

ATTRACT trial
Patients who have suffered from a first episode of unprovoked venous thromboembolism (VTE) have an eight times higher risk of recurrence if they stop...

RapidAI receives FDA 510(k) clearance for PE Triage & Notification

RapidAI
RapidAI announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance for its Rapid PE Triage & Notification product for...

Treatment of venous ulcers with the ClariVein OC: How low can...

This advertorial is sponsored by Merit Medical. A downloadable version can be found here. In this case series, Michael Tal (Jerusalem, Israel) explains how the...

Treatment of venous ulcers with the ClariVein OC: How low can...

This advertorial is sponsored by Merit Medical.  In this case series, Michael Tal (Jerusalem, Israel) explains how the ClariVein OC device (Merit Medical) offers a...

“Excellent outcomes” for Zilver Vena® venous stent sustained out to three...

This advertorial is sponsored by Cook Medical. A downloadable version can be found here. The Zilver Vena venous self-expanding stent system (Cook Medical) is associated...

“Excellent outcomes” for Zilver Vena® venous stent sustained out to three...

VIVO
This advertorial is sponsored by Cook Medical. The Zilver Vena venous self-expanding stent system (Cook Medical) is associated with high rates of patency by ultrasound,...

Venovo venous stent returns to US market after 2021 recall

Venovo
BD recently announced that its Venovo venous stent is back on the US market following a recall last year. In 2019, the company reported that...

Contemporary venous intervention reduces post-thrombotic syndrome in initial CLEAR-DVT analysis

In an initial cohort of patients enrolled in the CLEAR-DVT study, contemporary venous intervention resulted in an open vein, which reduced post-thrombotic syndrome (PTS)....

Koya Medical launches Dayspring lower extremity active compression treatments for lymphoedema...

Koya Medical recently announced the US commercial availability of its Dayspring active compression system for the treatment of lymphoedema and venous diseases in lower...

Penumbra announces the European launch of the Indigo system with Lightning...

Penumbra has announced that its Indigo aspiration system with Lightning 7 and Lightning 12 have secured CE mark and are now commercially available in...

I-Vasc announces €1.8 million Series A investment to launch its Velex...

I-Vasc, developer of the Velex device with its empty vein ablation (EVA) technology for the treatment of chronic venous insufficiency (CVI), has announced the...

Study finds increased risk of serious blood clots up to six...

COVID-19
A study from Sweden published by The BMJ recently finds an increased risk of deep vein thrombosis (DVT) up to three months after COVID-19 infection,...

Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...

Cordis
Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...

Vesper Medical acquisition adds key piece to Philips’ venous portfolio

Bert van Meurs, the chief business leader for Image Guided Therapy with Royal Philips, speaks to Venous News following the company’s acquisition of Vesper...

Dedicated vs. non-dedicated: Researchers place venous stenting under the spotlight at...

Venous stenting was a hot topic on the agenda of the recent American Venous Forum (AVF) annual meeting (23–26 February, Orlando, USA). Catching the audience’s...

CX 2022 venous and lymphatic challenges: “We are at a turning...

This year’s venous and lymphatic programme at the Charing Cross (CX) International Symposium 2022 (26–28 April, London, UK, in person and virtual) will cover...

CX returns to in-person format once more in the London spring

Charing Cross (CX) chair Roger Greenhalgh welcomes the vascular community to this year's symposium, due to be held 26–28 April in London, UK, and...

First patients enrolled in study evaluating Restrata for treatment of venous...

ATTRACT trial
Acera Surgical has announced its first patient enrolment in a multicentre, head-to-head clinical study evaluating Restrata for the treatment of non-healing venous leg ulcers...

Koya Medical secures US$26 million in Series B funding to advance...

Koya Medical has announced the close of a US$26 million Series B financing. The round was led by 3x5 Partners, along with new investors...

Risk of venous stent migration rare but probably underreported, systematic review...

Stephen Black viva 2019
Stent migration following treatment of acute iliofemoral thrombus or venous obstruction is “rare but may be underreported”, with the majority of reported cases being...

Office-based laboratory setting proves safe for iliac vein stenting

varicose vein management
A retrospective study of 1,223 iliac vein cases performed in three office-based laboratories (OBLs) shows a major complication rate of 0.41%, suggesting these procedures...

Prolonged TV watching may increase risk of venous thromboembolism

A new study reports that watching TV for four hours a day or more is associated with a 35% higher risk of venous thromboembolism...

Abre venous stent “remains safe and effective” out to 24 months,...

The Abre venous stent (Medtronic) remains safe and effective for the treatment of iliofemoral venous obstructive disease out to 24 months. This is according...

Thrombolex announces new interim data from RESCUE trial of the Bashir...

Thrombolex bashir
Thrombolex has announced positive results from the prespecified interim analysis of the first 62 evaluable pulmonary embolism (PE) patients enrolled in the investigational RESCUE...

ESVS publishes 2022 guidelines on management of chronic venous disease of...

The European Society for Vascular Surgery (ESVS) has released 2022 clinical practice guidelines on the management of chronic venous disease (CVD) of the lower...

ESVS CVD guideline writing committee “entirely renews structure” of recommendations

The European Society for Vascular Surgery (ESVS) has released 2022 clinical practice guidelines on the management of chronic venous disease (CVD) of the lower...

SWK Holdings provides US$10 million to MolecuLight to support global commercial...

MolecuLightDX
MolecuLight announced today that SWK Holdings has provided US$10 million structured debt to support MolecuLight’s global commercial expansion. SWK Holdings Corporation is a life science...

FDA approves two paediatric venous thromboembolism indications for Janssen’s Xarelto

The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced that the US Food and Drug Administration (FDA) has approved two paediatric indications for...

Vesper Medical announces completion of enrolment in the VIVID trial

Vesper Medical recently announced the completion of enrolment in its pivotal study—VIVID (Venous stent for the iliofemoral vein investigational clinical trial using the Vesper...

Philips acquires Vesper Medical

Royal Philips today announced that it has signed an agreement to acquire Vesper Medical, a US-based medical technology company that develops minimally-invasive peripheral vascular...

InterVene’s BlueLeaf endovenous valve formation system granted FDA Breakthrough Device designation

InterVene recently announced that it has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for the company’s BlueLeaf endovenous valve...

Compression stockings after endovenous thermal ablation of varicose veins “bring no...

Roshan Bootun application of compression stockings
A systematic review and meta-analysis published online in the European Journal of Vascular and Endovascular Surgery has suggested that, following endovenous thermal ablation of...

Recommendation for repeat imaging after incomplete ultrasound exam increases follow-up rate

The rate of follow-up after an incomplete and negative lower extremity venous duplex ultrasound (I/N LEVDUS) has been shown to increase following a specific...

BD acquires Venclose to extend chronic venous disease treatment portfolio

BD announced today it has acquired Venclose, a provider of solutions for the treatment of chronic venous insufficiency (CVI). "We are committed to setting a...

Milvexian an effective and safe oral pill for prevention of venous...

A worldwide study led by McMaster University in Hamilton, Canada, has shown that milvexian can be used to prevent venous blood clots with minimal...

Viz.ai launches two new AI-powered modules for pulmonary embolism and aortic...

Viz.ai has announced the US commercial launch of its AI-powered modules for pulmonary embolism and aortic disease. Debuting at VEITHsymposium 2021 (16–20 November, Orlando, USA), the...

Five-year data identify RD Global & Invamed’s VenaBlock cyanoacrylate ablation as...

VenaBlock
RD Global & Invamed recently announced that five-year results of a comparison between cyanoacrylate ablation (CAA) and radiofrequency ablation (RFA), showing that CAA with...

Mercator announces enrolment of first patient in DEXTERITY-AFP clinical trial treating...

Mercator Bullfrog
Mercator MedSystems has announced enrolment of the first patient in the DEXTERITY (Dexamethasone therapy examining reduction of inflammation after thrombus removal to yield benefit...

Researchers develop “world’s first” smart bandage that detects multiple biomarkers for...

chronic wound
A research team led by Lim Chwee Teck from the National University of Singapore’s (NUS; Singapore) Department of Biomedical Engineering  and Institute for Health...

Inari Medical announces six-month FLASH registry interim data

FlowTriever
Inari Medical has announced positive acute and long-term interim results from the first 500 pulmonary embolism (PE) patients enrolled in the FlowTriever outcomes registry...

Envveno Medical reports successful completion of first VenoValve surgery for US...

first-in-human
Envveno Medical, formerly Hancock Jaffe Laboratories, recently announced that the first VenoValve surgery in the company’s SAVVE US pivotal trial for the VenoValve has...

Venclose Maven earns FDA clearance to treat incompetent perforator veins

Venclose recently announced US Food and Drug Administration (FDA) 510(k) clearance for Venclose Maven, a novel radiofrequency (RF) ablation catheter for minimally invasive treatment...

Three-year VIVO results back “continued safety and effectiveness” of Zilver Vena...

VIVO
Three-year results of the VIVO clinical study support the continued safety and effectiveness of the Zilver Vena venous stent (Cook Medical) in the treatment...

Five-year, single-centre VenaSeal outcomes for symptomatic saphenous incompetence revealed

VenaSeal
Morwan Bahi (Wellington Regional Hospital, Wellington, New Zealand) presented five-year results of a retrospective, observational, single-centre study detailing outcomes for all patients with symptomatic...

Positive data for the EkoSonic endovascular system presented at VIVA 2021

EkoSonic
Boston Scientific announced positive results for the EkoSonic endovascular system (EKOS system) during a late-breaking clinical trial presentation at Vascular Interventional Advances (VIVA) 2021...

Thrombolex announces interim RESCUE results at VIVA 2021

Thrombolex bashir
Thrombolex recently announced the results of the RESCUE trial’s prespecified interim analysis, of the first 62 evaluable patients, in a late-breaking clinical trials session...

European College of Phlebology: Supporting phlebology in Europe

Venous News for specialists
This article is sponsored by the European College of Phlebology. It is a fact that the incidence of venous disease is rising; currently, 25% of...

Koya Medical receives FDA clearance for Dayspring Lite

Koya Medical has received US Food and Drug Administration (FDA) 510(k) clearance for its Dayspring Lite treatment for lymphoedema and venous disease. Unlike traditional...

Similar patency rates for endovascular and hybrid approaches to CVOs extending...

Houman Jalaie endovascular
In a comparison of endovascular versus hybrid treatment of chronic venous obstructions (CVOs) involving the confluence of the common femoral vein, researchers have found...

Inari Medical appoints pulmonologist Victor F Tapson as VP of Medical...

Inari Medical
Inari Medical has announced that the company has appointed Victor F Tapson as vice president of Medical Affairs. Tapson has devoted his medical career to...

Randomised study compares bare and radial fibres in EVLA

A single-centre, prospective, randomised trial suggests that endovenous laser ablation (EVLA) using a 1470nm laser with a bare fibre (BF) provided outcomes in the...

FDA approves first trial with Theraclion’s Sonovein therapy for varicose veins...

Theraclion
Theraclion has announced US Food and Drug Administration (FDA) approval for the first trial with Sonovein in the USA. After this clinical trial, a...

LSO Medical announces CE mark approval of Lumeseal laser for treatment...

LSO Medical has announced CE mark approval of its newest generation endovenous laser therapy (EVLT) SnakeBack assisted system, the Lumeseal laser platform. Designed to...

Boston Scientific announces agreement to acquire Devoro Medical

Today, Boston Scientific announced an agreement to acquire Devoro Medical, developer of the Wolf thrombectomy platform. The non-console and lytic-free Wolf technology targets and...

Thrombolex announces attendance at The VEINS and VIVA

Thrombolex bashir
Thrombolex has announced that it will be attending The VEINS (Venous Endovascular INterventional Strategies) conference (Booth T8) and VIVA (Vascular InterVentional Advances) Physicians conference...

“The future is very bright for venous valve replacement”

The progress of two “promising” new devices in the venous valve replacement space were outlined during a special session at the Society for Vascular...

Thromboprophylaxis with anticoagulants “likely effective” at preventing VTE post-vascular surgery, larger...

“Among patients undergoing vascular surgery, thromboprophylaxis with anticoagulants showed a trend towards reduced incidence of VTE when compared to placebo,” Tarek Haykal (Duke...

Towards new horizons: ESVS president introduces hybrid 35th Annual Meeting

Following an online-only conference in 2020, this year's iteration of the European Society for Vascular Surgery (ESVS) Annual Meeting will take a hybrid format,...

Durable healing outcomes of Topical Wound Oxygen (TWO2) therapy highlighted at...

Advanced Oxygen Therapy Inc (AOTI) has announced that its multimodality Topical Wound Oxygen (TWO2) therapy was recently highlighted at multiple leading international clinical conferences...

Global surgery study finds recent or current COVID-19 infection linked to...

COVID-19
New research published in Anaesthesia (a journal of the Association of Anaesthetists) shows that venous thromboembolisms (VTEs) are 50% more likely to occur in patients...

CHEST releases new guidelines for antithrombotic therapy for VTE disease

The American College of Chest Physicians (CHEST) recently released new clinical guidelines for venous thromboembolism (VTE) management, “Antithrombotic therapy for VTE disease: Second update...

Hancock Jaffe presents positive two-year VenoValve data at SVS VAM 2021

Hancock Jaffe Laboratories has announced that promising two-year post-VenoValve implantation data are being presented today at the Society for Vascular Surgery’s Vascular Annual Meeting...

Researchers find little benefit to stenting for degree of stenosis in...

A new study suggests that the degree of intravascular ultrasound (IVUS)-determined iliofemoral venous stenosis does not appear to affect the initial clinical presentation, clinical-etiologic-anatomic-pathophysiological...

Koya Medical secures first reimbursement codes for Dayspring compression system, announces...

Koya Medical recently announced that its wearable, active compression therapy system for lymphoedema—Dayspring—has been issued new billing codes by the Center of Medicare &...

Boston Scientific initiates randomised controlled trial for the EkoSonic endovascular system

Boston Scientific has commenced enrolment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the...

FDA grants Breakthrough Device designation status for Hancock Jaffe’s VenoValve

Hancock Jaffe Laboratories today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation status to the VenoValve, the company’s...

Case report: Recanalisation of chronic iliofemoral venous occlusion in a patient...

This advertorial, sponsored by BD, is only available in selected countries and geographies. In this case report for Venous News, experts outline the importance...

Philips receives FDA Breakthrough Device designation for laser-assisted IVC filter removal...

Royal Philips today announced the US Food and Drug Administration (FDA) has granted Breakthrough Device designation for a laser-assisted inferior vena cava (IVC) filter...

Case report: Recanalisation of chronic iliofemoral venous occlusion in a patient...

This advertorial, sponsored by BD, is only available in selected countries and geographies. A downloadable version of this advertorial can be found here. In this...

Transluminal injection of foam sclerotherapy combined with EVLA “safe and feasible”

Transluminal injection of foam sclerotherapy (TLFS) combined with endovenous laser ablation (EVLA) is a safe and feasible procedure that improves venous clinical severity score...

Laser crossectomy: Key takeaways from 2,300 cases over 12 years

Based on findings presented at the 21st European Venous Forum (EVF) Annual Meeting (24–26 June, online), Imre Bihari (A+B Clinic, Budapest, Hungary) speaks to...

Viz.ai and Avicenna.AI partner to launch AI-driven intelligent care coordination for...

Viz.ai has partnered with Avicenna.AI to enable intelligent care coordination and improve patient triage of patients suffering from pulmonary embolism (PE) and aortic disease. Avicenna.AI’s US...

Fist Assist Devices announces US distribution deal and sales launch

fist assist fa-1 device
Fist Assist Devices has announced a two-year affiliation with Airos Medical to commercialise and launch sales of the Fist Assist FA-1 device in the...

Surmodics builds thrombectomy portfolio with acquisition of Vetex Medical

Surmodics recently announced that it has acquired privately-held Vetex Medical Limited. The Galway, Ireland-based medical device developer and manufacturer has focused exclusively on venous...

SVT patients bear “significant risk” of thromboembolic complications at three months,...

Despite a high rate of initial anticoagulation, patients with isolated superficial vein thrombosis (SVT) are at risk of thromboembolic complications—including recurrent or extended SVT...

Iliac vein stenting for chronic venous obstruction “significantly” improves venous disease-specific...

Venous disease-specific quality of life (QoL), as measured by the VEINES (Venous insufficiency epidemiological and economic study)-QoL/Sym, improves significantly after iliac vein stenting for...

Thrombolex receives enhanced indication for use from the FDA

Thrombolex bashir
The US Food and Drug Administration (FDA) has enhanced the indications for use of the Bashir endovascular catheter (Thrombolex) and the Bashir Plus endovascular...

Janssen submits new drug application to US FDA for Xarelto (rivaroxaban)...

reduced hospital time and costs Xarelto anticoagulant
The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced it has submitted a new drug application (NDA) to the US Food and Drug...

Adjunctive compression to standard prophylaxis for postoperative VTE shows benefit in...

kirill lobastov
Among patients with a Caprini score of ≥11 who received standard prophylaxis for venous thromboembolism (VTE), adjunctive intermittent pneumatic compression (IPC) resulted in a...

Mayo Clinic study provides clarity on use of anticoagulants to treat...

cancer patient
A study by Mayo Clinic researchers provides some clarity on the use of direct oral anticoagulants (DOACs), such as apixaban and rivaroxaban, to treat...

CLOUT registry: Inari Medical announces positive interim results from first 250...

Inari Medical today announced "strongly positive" interim results from the first 250 deep vein thrombosis (DVT) patients enrolled in the CLOUT (ClotTriever outcomes) registry....

Propofol use during catheter-directed interventions for intermediate-risk PE associated with major...

A study suggests avoiding propofol for intraprocedural sedation during catheter-directed interventions (CDIs) for intermediate-risk pulmonary embolism (PE) because it can have detrimental effects. Propofol...

AI triage solution for PE and aortic dissection receives FDA clearance...

Medical imaging artificial intelligence (AI) specialist Avicenna.AI recently announced that it has received certification in the USA and European Union (EU) for CINA CHEST,...

Study launched to assess blood clot prediction model for paediatric patients

guidelines
Monroe Carell Jr Children's Hospital at Vanderbilt (Nashville, USA) has launched a study to determine the impact of a predictive model for identifying paediatric...

FDA clears Koya Medical’s Dayspring compression system for lower extremities

Koya Medical announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance for its active compression therapy system Dayspring for...

Boston Scientific and BD initiate venous stent recalls

Boston Scientific and BD have both initiated recalls of venous stents. According to a US Food and Drug Administration (FDA) medical device recall notice...

One-year outcomes from PROMISE I US study of LimFlow system published

LimFlow SA recently announced the publication of 12-month data from the full patient cohort in its PROMISE I study of the LimFlow percutaneous deep...

Recent advances in VTE management provide much-needed clarity, but more needs...

Manjit Gohel (Cambridge, UK) and Stephen Black (London, UK) write that several recent advances in the management of venous thromboembolism (VTE) have provided clarity...

Further research will soon generate standardised approach to VTE in COVID-19...

COVID-19
At VENOUS2021 (17–20 March, virtual), the annual meeting of the American Venous Forum, Geno Merli (Thomas Jefferson University Hospital, Philadelphia, USA) gave a keynote...

What an interventionalist needs to know about DOACs in 2021

The publication of positive new data and a need to minimise hospital visits during the COVID-19 pandemic has seen a general trend towards using...

Towards universal adoption: Development of the AVF and SVS EHIT guidelines

While various treatment regimens for the “unique complication” of endothermal heat-induced thrombosis (EHIT) following endovenous ablation have been developed, Lowell S Kabnick tells Venous...

Interview: Comprehensive, patient-friendly risk assessment “crucial” to VTE prevention

From the first research linking heparin to a reduction in fatal pulmonary embolism (PE), to the development and refinement of risk assessment tools to...

Marathon Medical wins inclusion of the Geko device on its Veterans...

geko OnPulse
Sky Medical Technology has announced the inclusion of its flagship product, the Geko device, on a US Veterans Health Administration (VA) Federal Supply Schedule...

First US patent issues on Hancock Jaffe VenoValve

Hancock Jaffe Laboratories has revealed that the United States Patent and Trademark Office (USPTO) has issued the first patent covering the company's VenoValve. The...

Hancock Jaffe receives IDE approval to begin VenoValve US pivotal trial

Hancock Jaffe Laboratories recently announced that the US Food and Drug Administration (FDA) has approved the company's Investigational Device Exemption (IDE) application to begin...

IVUS use in venous procedures improves stent patency

A recent study on iliac vein stenting showed better short- and mid-term patency rates when intravascular ultrasound (IVUS) was utilised prior to stent deployment...

High thrombotic risk in cancer patients receiving immunotherapy

cancer patient
According to a recent study, patients with cancer under immune checkpoint inhibitor therapy are at high risk of thromboembolism, especially venous thromboembolism (VTE). Furthermore,...

Inari Medical announces first patient enrolled in FLAME study

FlowTriever
Inari Medical has announced the enrolment of the first high-risk pulmonary embolism (PE) patient in the FLAME (FlowTriever for acute massive pulmonary embolism) study....

Outpatient-based warfarin monitoring programme safely adapts to COVID-19 challenges

COVID-19
Faced with a need to limit hospital visits and conserve personal protective equipment (PPE) in the wake of COVID-19, an 11-centre, hospital-based anticoagulation monitoring...

Researchers recommend national registries address geographical variation in DVT guideline implementation

A new review concludes that the implementation of clinical guidelines for the management of patients with deep vein thrombosis (DVT) varies among countries, from...

LimFlow receives Japan PMDA approval for clinical study of minimally-invasive technology

LimFlow announced today that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved its Clinical Trial Notification (CTN) for the Japanese cohort of...

Study on ELVeS Radial varicose vein laser therapy shows excellent long-term...

Long-term results of patients who underwent outpatient laser treatment for varicose veins at the great saphenous vein (GSV) or small saphenous vein (SSV) in...

Vetex Medical announces positive one-year outcomes for ReVene thrombectomy catheter

Vetex Medical has announced positive one-year outcomes from a European clinical study of the ReVene thrombectomy catheter. In patients with iliofemoral vein thrombus, the...

High rate of early reocclusion in patients who require recanalisation of...

guidelines
A new study has found that patients who require recanalisation of a completely occluded venous outflow tract before stenting have a high rate of...

Analysis finds correlation between GSV length of treatment zone and postablation...

According to a recent study, longer segments of great saphenous vein (GSV) reflux appear to correlate with symptom severity. In addition, researchers noted a...

CX to tackle key controversies in the venous space

Lowell Kabnick (Lake Worth, USA) talks to Venous News ahead of this year’s Charing Cross Symposium (CX), which is being held online 19–22 April. In...

Vetex Medical receives FDA clearance for ReVene thrombectomy catheter

Vetex Medical has announced US Food and Drug Administration (FDA) 510(k) clearance for the ReVene thrombectomy catheter. ReVene uses dual-action technology designed to de-clot...

Study suggests Villalta scale may better capture impact of post-thrombotic syndrome...

In a comparison of two clinical scales that assess quality of life (QoL) in post-thrombotic syndrome, Angela Lee (McGill University, Montreal, Canada) and colleagues...

Meta-analysis: IVC filters should be considered for certain patients at high...

In a recent meta-analysis, Yang Liu, Huan Lu (Henan Cancer Hospital, Zhengzhou, China), and colleagues found insufficient evidence to prove that inferior vena cava...

First-in-human results for the Bashir endovascular catheter published

Thrombolex bashir
Results of a first-in-human study to assess the safety and feasibility of the Bashir endovascular catheter (Thrombolex) for the treatment of acute intermediate-risk pulmonary...

First patient enrolled in postmarket clinical follow-up study of the BeYond...

The first patient has been enrolled in a postmarket clinical follow-up (PMCF) study of the BeYond venous self-expanding stent system (Bentley), a press release states....

Hancock Jaffe, maker of the VenoValve, completes US$41 million public offering

Hancock Jaffe Laboratories recently announced that it has completed a public offering of its securities, generating approximately US$41.4 million of gross proceeds, prior to...

Review of SVS VQI data reveals “dramatic reduction” in elective venous...

Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) venous case volume and registry data entry was “sharply reduced” during the initial phase of...

COMETA trial suggests compression stockings after endothermal ablation advantageous in the...

Roshan Bootun application of compression stockings
Outcomes of the COMETA (Compression following endothermal ablation) study were published in the February edition of Annals of Surgery. The results suggest that wearing...

Bayer receives approval in the UK for Xarelto to treat and...

reduced hospital time and costs Xarelto anticoagulant
Bayer has received approval in the UK for the use of its oral Factor Xa inhibitor Xarelto (rivaroxaban) to treat venous thromboembolism (VTE) and...

Long-term data revealed for VICI Venous Stent System

Michael Lichtenberg (Karolinen Hospital, Arnsberg, Germany) details three-year data from the Arnsberg venous registry on the VICI Venous Stent System (Boston Scientific). This video forms...

Three-year data add to growing body of clinical evidence in support...

Michael Lichtenberg
This advertorial is sponsored by Boston Scientific. The VICI Venous Stent System (Boston Scientific) is associated with excellent primary patency rates, with concomitant symptomatic improvement...

Three-year data add to growing body of clinical evidence in support...

The VICI Venous Stent System (Boston Scientific) is associated with excellent primary patency rates, with concomitant symptomatic improvement in Clinical-Etiological-Anatomical-Pathophysiological (CEAP) classification, directly after...

IVUS should be considered “essential equipment” in venous interventions, LINC 2021...

deep venous stenting
“I consider intravascular ultrasound (IVUS) to be essential equipment in venous interventions,” Rick de Graaf (Clinic of Friedrichshafen, Friedrichshafen, Germany) told viewers of LINC...

New medical device removes large blood clots in DVT patients

Control Medical Technology recently announced that their US Food and Drug Administration (FDA)-cleared Control 11F mechanical thrombectomy system has been used to remove large...

New study supports minimally invasive treatments for great saphenous vein incompetence

A large, prospective, single-centre, randomised trial from Spain comparing two open surgical techniques with radiofrequency ablation (RFA) to treat saphenous incompetence found RFA comparable...

Inari Medical announces presentation of positive chronic clot subanalysis results from...

Inari Medical has announced strongly positive interim results of the first 64 chronic deep vein thrombosis (DVT) patients enrolled in the ClotTriever outcomes (CLOUT)...

VTE management in COVID-19: “Use evidence-based prophylaxis and enrol patients in...

COVID-19
Venous thromboembolism (VTE) in COVID-19 patients was a key topic on the agenda of The VEINS (Venous Endovascular INterventional Strategies) session at VIVA 2020...

A multidisciplinary approach to VTE in COVID-19 patients is warranted

The nature of venous thromboembolism (VTE) in COVID-19 patients is complex, and treatment strategies regarding drug type and dosing continue to evolve, writes Sanjum...

Interview: New registry data provide “high-quality answers” on thromboembolic complications in...

Describing the Northwell CORE-19 registry as “the largest prospective registry of thromboembolic complications in hospitalised COVID-19 patients in the post-hospital discharge period,” lead investigator...

First ESVS guidelines on venous thrombosis published

The European Society for Vascular Surgery (ESVS) has produced a clinical practice guidelines document on the management of venous thrombosis—the first guidelines the society...

Results published from EXTRACT-PE trial of Penumbra’s Indigo aspiration system

Indigo
Results from the EXTRACT-PE trial, which found that Penumbra’s Indigo aspiration system met its predefined safety and efficacy endpoints for the treatment of pulmonary...

DATA study finds thermal aquatic immersion enhances clinical benefits of standardised...

A recent randomised controlled trial shows a potential role for higher density types of thermal water in lower limb volume control and quality of...

Innovation continues in thrombolytic-free thrombectomy

In this article for Venous News, Stephen A Black discusses innovation in the field of thrombolytic-free thrombectomy. He considers "exciting" new developments in mechanical-only...

DIVERSITY trial finds adjusted dabigatran dosing algorithm appropriate for treatment of...

In a recent randomised controlled trial, an age-adjusted, weight-adjusted dabigatran dosing algorithm was found to be appropriate in children under 18 years old with...

VTE-related factors and elevated bleeding risk associated with IVC filter placement...

In a recent study, factors related with venous thromboembolism (VTE) severity—including pulmonary embolism response team (PERT) referral from the intensive care unit (ICU) and...

Aidoc and Imbio partner to provide an AI solution to prioritise...

Aidoc and Imbio have announced a partnership intended to provide an end-to-end artificial intelligence (AI) solution for pulmonary embolism (PE), with the goal of ultimately...

Vesper Medical announces first enrolment in the VIVID trial

Vesper Medical recently announced initiation of its US Food and Drug Administration (FDA) investigational device exemption (IDE) study—VIVID (Venous stent for the iliofemoral vein investigational...

Monitoring interface pressure “essential” during compression therapy, study suggests

Fedor Lurie
In a study of interface pressure changes under compression bandages, Junjie Ning, Fedor Lurie (both Jobst Vascular Institute, Toledo, USA), and colleagues found that...

Zilver Vena venous self-expanding stent now available in the USA

Zilver Vena
Cook Medical has announced that their Zilver Vena venous self-expanding stent is now commercially available to physicians in the USA. Zilver Vena is a self-expanding...

Penumbra’s newest generation of Indigo aspiration system receives FDA clearance for...

Penumbra today announced US Food and Drug Administration (FDA) 510(k) clearance for expanded indication of the latest iteration of the Indigo aspiration system, Lightning...

Inari Medical announces presentation of 30-day follow-up results from first patients...

FlowTriever
Inari Medical has announced follow-up results of the first 230 patients enrolled in its FLASH study. FLASH is a real-world registry to study the...

Varixio Pod Air earns CE mark approval as medical device

Vascular Barcelona Devices (VB Devices) recently announced that its Varixio Pod Air product received CE mark approval as a Class 1s medical device. Varixio...

VELTAS document sets out “international standard” for triage of venous patients...

guidelines
In September 2020, a consensus document outlining the Venous and Lymphatic Triage and Acuity Scale (VELTAS) was co-published in Phlebology and the Journal of...

PROMISE I: LimFlow system enables vast majority of patients to avoid...

LimFlow SA has announced the presentation of one-year data from the full patient cohort in its PROMISE I study of the LimFlow percutaneous deep...

One-year VIVO results support safety and effectiveness of Zilver Vena venous...

Results of the VIVO clinical study support the safety and effectiveness of Cook Medical's recently FDA-cleared Zilver Vena venous stent for the treatment of...

FLASH registry: Interim results “reinforce the excellent FlowTriever safety profile”

FlowTriever
Catalin Toma (University of Pittsburgh, Pittsburgh, USA) recently presented interim results from the FLASH registry during a late-breaking session at TCT Connect (14–18 October,...

Compression garments that do not compress the foot and heel area...

compression
An off-label randomised controlled trial (RCT) has found that an investigational stocking, which has no compression in the foot or heel area, is significantly...

RCT finds addition of aquatic activity to chronic venous insufficiency treatment...

Results of the ATLANTIS (Aquatic therapy to lower adverse consequences of venous thrombosis and insufficiency) randomised controlled trial (RCT) show that the addition of...

Medtronic Abre stent receives US FDA approval to treat venous outflow...

Medtronic today announced it has received US Food and Drug Administration (FDA) approval for the Abre venous self-expanding stent system. This device is indicated...

The BASHIR™ Endovascular Catheter: Delivering a complete solution for arterial and...

The BASHIR™ Endovascular Catheter offers a safe and easy-to-use platform technology, creating immediate blood flow, accelerating thrombolysis, and dissolving large volumes of thrombus burden....

BAS Vein Treatment Masterclasses take off

The BAS (British Association of Sclerotherapists) interactive Masterclass Series kicked off on 8 October with three experts from the world of vascular surgery sharing...

Zilver Vena venous self-expanding stent receives FDA approval to market in...

Zilver Vena
Cook Medical today announced that the Zilver Vena received US Food and Drug Administration (FDA) premarket approval (PMA) in the USA. The product is...

Systematic review finds high risk of deep vein thrombosis and pulmonary...

In a systematic review of the worldwide published data on venous thromboembolism (VTE) in COVID-19 patients, Cihan Ay, Stephan Nopp, and Florian Moik (Medical...

Comparable risk of recurrent VTE between patients with unprovoked VTE and...

cancer patient
Patients with venous thromboembolism (VTE) carry a high risk of recurrence. Accordingly, a 16-year Danish prospective cohort study of nearly 74,000 patients with incident VTE...

AVF schedules education series for trainees, early-career practitioners

The American Venous Forum (AVF) is to stage a four-part series of educational sessions aimed at residents, fellows, and early-career practitioners in vascular surgery,...

Intracranial haemorrhage rare in patients treated with catheter-directed thrombolysis for proximal...

In a recent nationwide study of observational data from the USA, intracranial haemorrhage (ICH) was found to be rare among deep vein thrombosis (DVT)...

Concomitant and staged varicose tributary interventions are both safe and effective...

A recent systematic review and meta-analysis compared the outcomes of both concomitant and staged superficial varicose tributary (SVT) interventions as an adjunct to endovenous...

Society of Interventional Radiology publishes IVC filter guidelines

guidelines
The Society of Interventional Radiology (SIR) recently published new clinical practice guidelines that provide evidence-based recommendations on the use of inferior vena cava (IVC)...

Braided as compared with laser-cut nitinol stents achieve favourable primary patency...

VTE
In a recent analysis of 150 patients with post-thrombotic syndrome included in the Swiss and Arnsberg venous stent registries, braided as compared with laser-cut...

Study finds US incidence of cerebral venous thrombosis is on the...

A new analysis has found that the incidence of cerebral venous thrombosis (CVT) in the USA is higher than previously reported and has increased...

HOME-PE trial clarifies which patients with acute PE can be managed...

Patients with acute pulmonary embolism (PE) can be selected for home management using the sPESI score or the Hestia criteria, according to results of...

Venovo venous stent system nominated for Prix Galien award

Venovo
The Venovo venous stent system from BD has been revealed as one of the 2020 50th Annual Prix Galien USA award nominees in the...

Study finds 3D computed tomography venogram is a useful diagnostic tool...

A recently-published study concludes that three-dimensional (3D) computed tomography venogram (CTV) enables accurate diagnosis and treatment of patients presenting with symptomatic chronic iliofemoral venous...

Study finds death rates from PE have been rising over the...

The American Heart Association (AHA) has announced that after nearly a decade of steady decline, the death rate for people with pulmonary embolism (PE)...

RCT: Technical success rates of mechanochemical ablation are inferior to thermal...

Three-year results of a randomised controlled trial reveal that, while mechanochemical ablation (MOCA) is a “feasible treatment option” in an outpatient setting, its technical...

First patient enrolled in RESCUE trial of Thrombolex’s Bashir catheter

Thrombolex bashir
Thrombolex has announced that it has enrolled the first patient in its pivotal RESCUE trial for the treatment of patients with acute submassive pulmonary...

DOACs show promise over heparin injections in meta-analysis comparing cancer-associated VTE...

cancer patient
A recent meta-analysis found that direct oral anticoagulants (DOACs) appear to be a “reasonable alternative” to low molecular weight heparin (LMWH) for the treatment...

Compression after radiofrequency ablation of varicose veins “adds no clinical benefit”

compression
A randomised controlled trial has found that clinical and patient-reported outcomes following radiofrequency ablation (RFA) of varicose veins with compression are no better than...

Bentley enters venous world with launch and first-in-man of BeYond stent

Bentley has announced receipt of the CE mark for its BeYond venous self-expanding stent system. The company will initially launch the stent to an...

PolarityTE announces positive top-line data from interim analysis of SkinTE diabetic...

PolarityTE have announced positive results from a protocol-specified interim analysis of the first 50 patients enrolled in a multicentre randomised controlled trial evaluating treatment...

COVID-19 associated VTE: International thrombosis community urge WHO to act

COVID-19
The International Society on Thrombosis and Haemostasis (ISTH), on behalf of the international thrombosis community, have called on the World Health Organisation (WHO) to...

Rivaroxaban associated with reduced risk of recurrent VTE versus warfarin in...

Olivia S Costa
In a study evaluating rivaroxaban (Xarelto; Bayer) versus warfarin for the treatment and prevention of recurrent venous thromboembolism (VTE) in patients with obesity, results...

Study reports low rates of bleeding and VTE after 12 months...

Daiichi Sankyo Europe GmbH has announced results from five analyses of 12-month data from ETNA-VTE (Edoxaban treatment in routine clinical practice in patients with...

AHA and ISTH release joint statement on future VTE research priorities

The International Society on Thrombosis and Haemostasis (ISTH) and the American Heart Association (AHA) have released a joint scientific statement identifying the top five priorities for...

Thrombolex receives NIH grant to fund RESCUE trial of Bashir endovascular...

Thrombolex bashir
Thrombolex has announced that it was awarded a US$3 million Small Business Innovation Research (SBIR) grant from the National Heart, Lung and Blood Institute...

Women are at a higher risk of iliac vein stent failure

A recent study on iliac vein stenting showed lower long-term patency rates for women when compared to their male counterparts. The data were presented...

CX 2020 LIVE: Overwhelming 91% of specialist audience favours venous stents

A poll of an enthused audience of venous specialists during the CX 2020 LIVE Deep Venous Disease Consensus session found that 91% of them were in...

ABRE study meets primary safety and effectiveness endpoints

Medtronic has announced the first-ever results from the ABRE clinical study assessing the safety and effectiveness of the investigational Abre venous self-expanding stent system...

Venous News 14 – June 2020

In this issue: Compression stockings might not be needed to prevent blood clots after surgery (p. 1) CX 2020 LIVE brings superficial venous thrombosis...

CX 2020 LIVE addresses latest developments in superficial venous disease

For the first venous session of CX 2020 LIVE, 759 attendees from 79 different countries tuned in. Each audience member could submit their name,...

VisionQuest Biomedical and The University of New Mexico combine artificial intelligence...

VisionQuest Biomedical and the University of New Mexico School of Medicine have been awarded a three-year US$3 million grant from the National Institute of...

New study shows COVID-19 causes severe blood vessel damage

COVID-19
New research published in the New England Journal of Medicine shows that the respiratory virus SARS-CoV-2, which causes COVID-19, causes severe damage to blood...

At six months, adjunctive mechanical thrombectomy associated with higher patency and...

Michael Lichtenberg
A recent systematic review and meta-analysis showed that, in patients with iliofemoral deep vein thrombosis (DVT), percutaneous mechanical thrombectomy was associated with a higher...

CX 2020 LIVE to flag latest guidelines and stent durability in...

Manj Gohel (Cambridge, UK), who is also a member of the CX Venous Executive Board, welcomes you to CX 2020 LIVE, which will include...

American Heart Association issues call to action to prevent VTE in...

Venous thromboembolism (VTE) is the leading cause of preventable hospital death in the USA and worldwide. A new policy statement by the American Heart...

Positive two-year data from ALPS registry of LimFlow system published

LimFlow SA today announced publication of positive two-year data from the ALPS registry of the LimFlow percutaneous deep vein arterialisation (pDVA) system. Results were...

Geko device represents an alternative to IPC devices during COVID-19

geko OnPulse
Sky Medical Technology highlights a publication on 5 May 2020 in the Journal of Thrombosis and Haemostasis showing the incidence of venous thromboembolism (VTE) in...

The future of IVUS based therapies for venous leg ulcers

VIVO
Writing for Venous News, Paul Gagne considers the future of intravascular ultrasound (IVUS) based therapies for venous leg ulcers (VLUs). He concludes that while...

CX 2020 LIVE: Charing Cross Symposium unveils live, interactive digital event

The Charing Cross (CX) Symposium, with its world-class faculty and unique focus on live audience participation, has announced the launch of a not-to-be missed...

Compression stockings might not be needed to prevent blood clots after...

compression
Compression stockings might be unnecessary to prevent blood clots in most patients undergoing non-emergency (elective) surgery, finds a clinical trial published by The BMJ...

FDA clears Aspire MAX mechanical thrombectomy system

Control Medical Technology has announced that the US Food and Drug Administration (FDA) has cleared its Aspire MAX 7 – 11F mechanical thrombectomy...

A Deeper Dive into the Venovo™ Venous Stent System

Venovo venous stent
The venous space continues to evolve in the United States, and many physicians are learning how to navigate through the challenges of the venous...

A Deeper Dive into the Venovo™ Venous Stent System

Venous News talks with Gerard O'Sullivan, FSIR, FEBIR, University College Hospital, Galway, Ireland. This article is supported by BD Interventional. Disclosures: Dr. Gerard O'Sullivan reports...

New study addresses thromboembolic complications in COVID-19 patients

COVID-19
There is an “urgent need” to improve specific venous thromboembolism (VTE) diagnostic strategies and investigate the efficacy and safety of thromboprophylaxis in ambulatory COVID-19...

2020 update to CEAP classification system and reporting standards published

Fedor Lurie
A 2020 update on the Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification system and reporting standards, authored by Fedor Lurie (Jobst Vascular Institute, Toledo, USA; University of Michigan,...

AVF releases white paper on considerations in prophylaxis and treatment of...

The COVID-19 subcommittee of the American Venous Forum (AVF) has issued a white paper on considerations in prophylaxis and treatment of venous thromboembolism (VTE)...

COVID-19: Reflections on VTE, patient risk assessment, and therapeutic challenges

Joseph A Caprini considers venous thromboemolism (VTE), patient risk assessment, and therapeutic challenges in the wake of the COVID-19 pandemic, concluding that "accurate thrombosis...

COVID-19: what will be the fallout for patients with venous disease?

Manj Gohel, Stephen Black and Alun Davies consider the impact of the COVID-19 pandemic on patients with venous disease. They conclude: "Once the acute...

Philips and the US government collaborate in ventilator production ramp up...

Royal Philips has announced that the US government and Philips agreed to team up to increase the production of hospital ventilators in its manufacturing...

ACS defends healthcare workers as PPE shortages lead to acrimony

The American College of Surgeons (ACS) today leapt to the defense of healthcare workers who are heading to work in the face of increasing...

CX 2020 is cancelled due to COVID-19

The 2020 Charing Cross (CX) Symposium that was due to take place next month in London, UK, has been cancelled due to COVID-19.  In full,...

FDA grants de novo clearance to Bluegrass Vascular for Surfacer system

bluegrass vascular trial results
Bluegrass Vascular Technologies (Bluegrass Vascular) announced today that the US Food and Drug Administration (FDA) has granted a de novo classification order for its...

XableCath crossing catheters have received CE mark for peripheral use

XableCath has announced that its XableCath Crossing catheters have received CE mark for peripheral use. Its crossing devices will be available for sale in...

Biolitec reveals new ELVeS Radial 2ring Pro laser fibre for severely...

ELVeS Radial 2ring Pro laser fibre
Biolitec has announced the addition of another laser fibre to its ELVeS Radial 2ring laser fibre range. The ELVeS Radial 2ring Pro enables the...

Insera announces first-in-human treatment of patient with PE using CLEAR aspiration...

Insera Therapeutics announced recently that the first patient with acute pulmonary embolism has been treated with its flagship cyclical aspiration system, CLEAR. Earlier last...

Bluegrass Vascular announce publication of positive clinical results of Surfacer system

bluegrass vascular trial results
Bluegrass Vascular Technologies (Bluegrass Vascular) has announced the publication of positive results associated with the clinical use of the Surfacer Inside-Out access catheter system...

PIUR Imaging launches wireless tomographic ultrasound system

PIUR Imaging has launched a portable version of its tomographic ultrasound system to the European market. The new CE-marked PIUR tUS Infinity is a...

The optimal pathway for acute deep vein thrombosis treatment involves identification,...

Prakash Saha (London, UK), speaking during the Venous and Lymphatic Challenges programme at CX (15–18 April, London, UK), outlined the three key steps to...

Ramesh Tripathi

Having worked as a vascular surgeon and venous specialist in several different countries and continents, Ramesh Tripathi has a wide-ranging experience and storied career. He...

Choosing compression to heal venous leg ulceration

Venous leg ulcer with Una Adderley
There is a robust evidence base to support the use of compression therapy for healing venous leg ulceration and for preventing ulcer recurrence. The most...

Intraluminal narrowing as a predicting factor for stent occlusion

A recent study which set out to investigate the usefulness of duplex ultrasound in monitoring stent changes over time, concludes that stent occlusion is related...

Worse outcomes in peripartum compared to non-pregnant women stented for DVT

Venous News for specialists
Peripartum women with deep vein thrombosis (DVT) treated with catheter-directed thrombolysis and venous stenting had significantly increased rates of reintervention and loss of stent patency...

Use of diode laser to treat venous malformations effective and safe...

Venous News for specialists
A report of an eight-year experience using diode laser for the treatment of congenital diffuse venous malformations, has shown the modality to be effective...

MOCAP linked with improved quality of life and fewer reinterventions for...

Venous News for specialists
A study presented at the European Society for Vascular Surgery’s annual meeting (ESVS; 25–28 September, Valencia, Spain) has concluded that mechanochemical ablation with concomitant...